Literature DB >> 15572375

An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements.

Karla A Temple1, Ronald N Cohen, Sarah R Wondisford, Christine Yu, Dianne Deplewski, Fredric E Wondisford.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) interacts with retinoid X receptor (RXR) on PPAR response elements (PPREs) to regulate transcription of PPAR-responsive genes. To investigate the binding of PPARgamma and RXR to PPREs, three mutations were constructed in the DNA-binding domains of PPARgamma; two of the mutants maintained the structure of zinc finger I (PPARgamma-GS and PPARgamma-AA), and a third mutation disrupted the protein structure of zinc finger I (PPARgamma-CS). Results indicated that the mutations of PPARgamma that maintained intact zinc fingers were capable of binding to a variety of PPREs in the presence of RXR and could activate transcription on several PPREs. In parallel, a mutation was created in the DNA-binding domain of RXRalpha that maintained the structure of the zinc fingers (RXR-GS) but did not bind DNA and was transcriptionally inactive. Examination of the 3' half-site of several PPREs revealed that variations from the consensus sequence reduced or abolished transcriptional activity, but conversion to consensus improved transcriptional activity with PPARgamma-GS and PPARgamma-AA. Examination of the 5' half-site indicated that the upstream three nucleotides were more important for transcriptional activity than the downstream three nucleotides. Our data demonstrated that stringent binding of RXR to the 3' half-site of a PPRE is more influential on the binding of the PPARgamma/RXR heterodimer than the ability of PPARgamma to bind DNA. Thus, unlike RXR, PPARgamma exhibits promiscuity in binding on a PPRE, suggesting that the definition of a PPRE for PPARgamma may need to be expanded.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572375     DOI: 10.1074/jbc.M411422200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis.

Authors:  Ronni Nielsen; Thomas Askov Pedersen; Dik Hagenbeek; Panagiotis Moulos; Rasmus Siersbaek; Eva Megens; Sergei Denissov; Michael Børgesen; Kees-Jan Francoijs; Susanne Mandrup; Hendrik G Stunnenberg
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

2.  Altered mitochondrial apoptotic pathway in placentas from undernourished rat gestations.

Authors:  Louiza Belkacemi; Mina Desai; D Michael Nelson; Michael G Ross
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-14       Impact factor: 3.619

3.  PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale.

Authors:  Martina I Lefterova; Yong Zhang; David J Steger; Michael Schupp; Jonathan Schug; Ana Cristancho; Dan Feng; David Zhuo; Christian J Stoeckert; X Shirley Liu; Mitchell A Lazar
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

4.  Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.

Authors:  David L M van der Meer; Tatjana Degenhardt; Sami Väisänen; Philip J de Groot; Merja Heinäniemi; Sacco C de Vries; Michael Müller; Carsten Carlberg; Sander Kersten
Journal:  Nucleic Acids Res       Date:  2010-01-27       Impact factor: 16.971

5.  Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation.

Authors:  Robert M Sargis; Daniel N Johnson; Rashikh A Choudhury; Matthew J Brady
Journal:  Obesity (Silver Spring)       Date:  2009-11-19       Impact factor: 5.002

6.  In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter.

Authors:  Dhananjay Gupta; Thomas L Jetton; Richard M Mortensen; Sheng Zhong Duan; Mina Peshavaria; Jack L Leahy
Journal:  J Biol Chem       Date:  2008-08-21       Impact factor: 5.157

7.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

8.  Peroxisome proliferator-activated receptor and vitamin d receptor signaling pathways in cancer cells.

Authors:  Satoru Matsuda; Yasuko Kitagishi
Journal:  Cancers (Basel)       Date:  2013-10-21       Impact factor: 6.639

Review 9.  The Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) in Adipogenesis: Applying Knowledge from the Fish Aquaculture Industry to Biomedical Research.

Authors:  Rebecca Wafer; Panna Tandon; James E N Minchin
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-22       Impact factor: 5.555

10.  Tributyltin differentially promotes development of a phenotypically distinct adipocyte.

Authors:  Shane M Regnier; Essam El-Hashani; Wakanene Kamau; Xiaojie Zhang; Nicole L Massad; Robert M Sargis
Journal:  Obesity (Silver Spring)       Date:  2015-08-04       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.